Download PDF Brochure @ Market Overview The global GLP-1 analogues market, valued at US$37.4 billion in 2023, is forecasted to grow at a robust CAGR of 33.2%, reaching US$47.4 billion in 2024 and an impressive US$471.1 billion by 2032.The expansion of the market is being fueled by increased awareness of metabolic disorders, innovations in drug delivery, and new indications beyond diabetes
Sign up for our newsletter Receive all the latest information on events, sales, & offers
Understanding these helps guide testing and treatment
Side Effects and Tolerability Ozempic is associated with gastrointestinal symptoms , while peptides tend to have minimal side effects
Reach Us MR JITENDER PAL (Sales) Akshar Molecules 268, Phase 1, HSIIDC Sonipat - 131001, Haryana, India Get Directions
Why is retatrutide not available as a tablet or capsule